Rethinking Blood Pressure Treatment and Dementia Risk in Older Adults: Is Adherence the Holy Grail?

J Am Coll Cardiol. 2024 Apr 2;83(13):1204-1206. doi: 10.1016/j.jacc.2024.02.021. Epub 2024 Mar 25.

Authors

Clinton B Wright¹, Marco Egle²

Affiliations

¹ Division of Clinical Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: wright.clinton@gmail.com.
² Intramural Stroke Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.

PMID: 38538199
DOI: 10.1016/j.jacc.2024.02.021

No abstract available

Keywords: antihypertensive drugs; blood pressure control; cognitive decline; dementia; frailty; old age.

Publication types

Editorial

MeSH terms

Aged
Antihypertensive Agents / pharmacology
Antihypertensive Agents / therapeutic use
Blood Pressure
Cognitive Dysfunction*
Dementia* / epidemiology
Humans
Hypertension* / drug therapy
Hypertension* / epidemiology

Substances

Antihypertensive Agents